80 related articles for article (PubMed ID: 17482142)
1. Attenuation of DNA damage checkpoint by PBK, a novel mitotic kinase, involves protein-protein interaction with tumor suppressor p53.
Nandi AK; Ford T; Fleksher D; Neuman B; Rapoport AP
Biochem Biophys Res Commun; 2007 Jun; 358(1):181-8. PubMed ID: 17482142
[TBL] [Abstract][Full Text] [Related]
2. Expression of PDZ-binding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF.
Nandi AK; Rapoport AP
Leuk Res; 2006 Apr; 30(4):437-47. PubMed ID: 16171862
[TBL] [Abstract][Full Text] [Related]
3. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
[TBL] [Abstract][Full Text] [Related]
4. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.
Castedo M; Perfettini JL; Roumier T; Yakushijin K; Horne D; Medema R; Kroemer G
Oncogene; 2004 May; 23(25):4353-61. PubMed ID: 15048074
[TBL] [Abstract][Full Text] [Related]
5. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
Mannefeld M; Klassen E; Gaubatz S
Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
[TBL] [Abstract][Full Text] [Related]
6. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2.
Jackson MW; Agarwal MK; Yang J; Bruss P; Uchiumi T; Agarwal ML; Stark GR; Taylor WR
J Cell Sci; 2005 May; 118(Pt 9):1821-32. PubMed ID: 15827088
[TBL] [Abstract][Full Text] [Related]
7. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
Yuan JH; Feng Y; Fisher RH; Maloid S; Longo DL; Ferris DK
Mol Cancer Res; 2004 Jul; 2(7):417-26. PubMed ID: 15280449
[TBL] [Abstract][Full Text] [Related]
8. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1.
Vigneron A; Roninson IB; Gamelin E; Coqueret O
Cancer Res; 2005 Oct; 65(19):8927-35. PubMed ID: 16204065
[TBL] [Abstract][Full Text] [Related]
9. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
Li C; Lin M; Liu J
Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
[TBL] [Abstract][Full Text] [Related]
10. PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response.
Ayllón V; O'connor R
Oncogene; 2007 May; 26(24):3451-61. PubMed ID: 17160018
[TBL] [Abstract][Full Text] [Related]
11. Bleomycin-induced over-replication involves sustained inhibition of mitotic entry through the ATM/ATR pathway.
Nakayama Y; Igarashi A; Kikuchi I; Obata Y; Fukumoto Y; Yamaguchi N
Exp Cell Res; 2009 Sep; 315(15):2515-28. PubMed ID: 19527713
[TBL] [Abstract][Full Text] [Related]
12. Enhanced phosphorylation of p53 serine 18 following DNA damage in DNA-dependent protein kinase catalytic subunit-deficient cells.
Araki R; Fukumura R; Fujimori A; Taya Y; Shiloh Y; Kurimasa A; Burma S; Li GC; Chen DJ; Sato K; Hoki Y; Tatsumi K; Abe M
Cancer Res; 1999 Aug; 59(15):3543-6. PubMed ID: 10446957
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying the pro-survival pathway of p53 in suppressing mitotic death induced by adriamycin.
Lin YC; Wang FF
Cell Signal; 2008 Jan; 20(1):258-67. PubMed ID: 18006273
[TBL] [Abstract][Full Text] [Related]
14. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation.
Ismail IA; Kang KS; Lee HA; Kim JW; Sohn YK
Eur J Pharmacol; 2007 Dec; 575(1-3):12-20. PubMed ID: 17706963
[TBL] [Abstract][Full Text] [Related]
15. Signaling of DNA damage is not sufficient to induce p53 response: (re)activation of wt p53 protein strongly depends on cellular context.
Wesierska-Gadek J; Gueorguieva M; Komina O; Schmid G; Kramer MP
J Cell Biochem; 2008 Apr; 103(5):1607-20. PubMed ID: 17879942
[TBL] [Abstract][Full Text] [Related]
16. Novel BRCA2-interacting protein BJ-HCC-20A inhibits the induction of apoptosis in response to DNA damage.
Tomiyoshi G; Nakanishi A; Takenaka K; Yoshida K; Miki Y
Cancer Sci; 2008 Apr; 99(4):747-54. PubMed ID: 18307534
[TBL] [Abstract][Full Text] [Related]
17. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.
Park JH; Lin ML; Nishidate T; Nakamura Y; Katagiri T
Cancer Res; 2006 Sep; 66(18):9186-95. PubMed ID: 16982762
[TBL] [Abstract][Full Text] [Related]
18. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
[TBL] [Abstract][Full Text] [Related]
19. Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.
Puca R; Nardinocchi L; Gal H; Rechavi G; Amariglio N; Domany E; Notterman DA; Scarsella M; Leonetti C; Sacchi A; Blandino G; Givol D; D'Orazi G
Cancer Res; 2008 May; 68(10):3707-14. PubMed ID: 18483253
[TBL] [Abstract][Full Text] [Related]
20. p53 activates G₁ checkpoint following DNA damage by doxorubicin during transient mitotic arrest.
Hyun SY; Jang YJ
Oncotarget; 2015 Mar; 6(7):4804-15. PubMed ID: 25605022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
